Côte d'Ivoire vs Lithuania: Mental health and substance use disorders deaths
Côte d'Ivoire
304.66 deaths
in 2021
Lithuania
301.12 deaths
in 2021
Côte d'Ivoire rank
81st
Lithuania rank
83rd
Mental health and substance use disorders deaths over time
- Côte d'Ivoire
- Lithuania
How they compare
Côte d'Ivoire currently reports 304.66 deaths against 301.12 deaths in Lithuania, a difference of 3.54 deaths.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Lithuania ahead.
Côte d'Ivoire ranks 81st and Lithuania ranks 83rd of 194 countries.
Across the 3 decades both report, Côte d'Ivoire averaged higher in 1 and Lithuania in 2.
Head to head by decade
| Decade | Côte d'Ivoire | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 148 deaths | 583.85 deaths | 435.85 deaths | Lithuania |
| 2010s | 260.68 deaths | 413.88 deaths | 153.2 deaths | Lithuania |
| 2020s | 296.51 deaths | 292.8 deaths | 3.71 deaths | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mental health and substance use disorders deaths, Côte d'Ivoire or Lithuania?
- Côte d'Ivoire, at 304.66 deaths against 301.12 deaths in Lithuania as of 2021.
- What is the difference in mental health and substance use disorders deaths between Côte d'Ivoire and Lithuania?
- 3.54 deaths, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Lithuania?
- 22 years are reported by both, from 2000 to 2021.
- How do Côte d'Ivoire and Lithuania rank globally for mental health and substance use disorders deaths?
- Côte d'Ivoire ranks 81st and Lithuania ranks 83rd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Mental health and substance use disorders deaths. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from mental and substance use disorders in both sexes.